Federated Hermes
SCPH

Federated Hermes’s scPharmaceuticals SCPH Stock Holding History

Federated Hermes’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-55
Closed -$560 – 2187
2023
Q2 		$560 Sell
55
-206
-79% -$2.15K ﹤0.01% 2052
2023
Q1 		$2.37K Buy
+261
New +$1.91K ﹤0.01% 1994
2020
Q4 		– Sell
-87
Closed -$1K – 2313
2020
Q3 		$1K Sell
87
-168
-66% -$1.31K ﹤0.01% 2188
2020
Q2 		$2K Buy
+255
New +$2.24K ﹤0.01% 2092
2019
Q4 		– Sell
-42
Closed -$1K – 2296
2019
Q3 		$1K Buy
+42
New +$237 ﹤0.01% 2131

Other funds holding SCPH

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
CAC
Cowen and Company New York $2.9B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return